Bio-Key International Re-files S-1 for U.S. IPO After Prior Withdrawal
Bio-Key International Inc. (NASDAQ: BKI) re-filed its S-1 registration statement with the SEC on October 9, 2026 — its second IPO attempt after withdrawing a prior filing in 2021. The new filing updates use of proceeds, capital structure, and executive biographies.
51CFO view：Re-filing requires CFOs to justify prior withdrawal, ensure financial continuity, and align executive bios across all SEC filings (8-K, 10-K). Any gap or ambiguity in CFO’s own background — especially outside SEC-regulated markets — triggers SOX internal control documentation requirements ahead of review.
Bio-Key International Inc. (NASDAQ: BKI) re-filed its S-1 registration statement with the SEC on October 9, 2026 — its second IPO attempt after withdrawing a prior filing in 2021. The new filing updates use of proceeds, capital structure, and executive biographies.
Source：SEC EDGAR · S-1 招股书备案
Why this matters to your CFO search
Where this touches your finance hire
Every listing event changes what you need from a CFO. Start from the step you are actually at.
What kind of CFO does a US IPO need?
S-1 / F-1 filing, US GAAP conversion, roadshow — the hard requirements.
Read →
Who owns SEC reporting and US GAAP?
Signature responsibility for 10-K / 10-Q / 8-K / 20-F, and common comments.
Read →
Who runs finance through a SPAC merger?
De-SPAC files F-1 / 424(b); merger audit and disclosure cadence differ.
Read →